World Health Organization : Year 1988 ; Mental Health Pad 88.1: Report of the World Health Organization Working Group on the Role of Schools of Pharmacy in the Rational Use of Psychoactive Drugs

By B. Rexed

Book Id: WPLBN0000075790
Format Type: PDF eBook
File Size: 1.0 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 1988 ; Mental Health Pad 88.1: Report of the World Health Organization Working Group on the Role of Schools of Pharmacy in the Rational Use of Psychoactive Drugs
Author:	B. Rexed
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Rexed, B. (n.d.). World Health Organization : Year 1988 ; Mental Health Pad 88.1. Retrieved from http://www.self.gutenberg.org/

Description
Medical Reference Publication

Excerpt
1. INTRODUCTION This report relates to the full range of psychoactive drugs, which includes psychotropic drugs (see Definitions). C ncern has been growing about the increasing and widespread use of psychotropic drugs.' This concern has arisen because the drugs are prescribed not only for mencal illnesses but also as a pharmacological response to personal and social problems, a practice chat has profound implications for doctors and for society as a whole. Furthermore, longe ex erience of psychotropic drugs has shown that they have 5 a greater liability to abuse and dependence than was initially believed. The use and abuse of psychotropic drugs should not, however, be seen in isolation. Hypnotics, anxiolytics, narcotic analgesics, and anti-deptessancs are part of the whole spectrum of psychoactive drugs which are liable to being abused. At one extreme are substances which are prepared and used illicitly, and at the other are licit drugs which may be available with or without prescription and are used for medicinal and recreational purposes.

Table of Contents
CONTENTS 1 . Introduction ............................................................... 2 2 . Objectives of the Working Group ................ ............ 3 3 . Proceedings ................................... . . . . . . . . . . . 1* 4. Definitions .................................. ....0 . .\ . . . . . . . . . . . . . . . . . .E.J .'J. .'.'. * . . . .s. . . . . . . . . . . . . 1 Psychoactive/psychotropic drugs 5 & . 2 Rational use ............................. 6; 8 . . . . . . . . . . . . . 5 34 PPhhaarrmmaacciys st up.p.o.r.t.. s..t.a.f.f. .......................................5. .. ........ . . ........................ 55 (1.5 Comuniry health worker . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 5 . Psychoactive drugs . the currenr situation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 5.L The availability of psychoactive drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 5.2 Controls .............................................................. 6 5.3 Availability and distribution of manpower . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 5.4 Factors affecting the rational prescribing of psychoactive drugs . . . . . . 8 6 . Pharmacy practice activities related to promoting the rational use and preventing the abuse of psychoactive dmgs ................................. 8 6.1 Community pharmacy .................................................... 8 6.2 Bospitals/institutlons ................................................ 9 6.3 The pharmaceutical industry ........................................... 9 6 . k Government ............................................................ 20 6.5 Academic activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 6.6 National and international agencies and professional bodies . . . . . . . . . . . 11 6.7 Training other health care workers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 6.8 Health promotion campaigns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 7 . Implicarions for schools of pharmacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 7.1 Undergraduate education in psychoactive drugs . . . . . . . . . . . . . . . . . . . . . . . . . 12 c 7 . 2 Other aspects of undergraduate education and training related to the pharaacist's role in the rational use of psychoactive drugs . . . . . . . . . . . 14 7.3 Curriculum management and evaluation of performance . . . . . . . . . . . . . . . . . . . 15 7.1 Postgraduate and continuing educarion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 7.5 Research and other forms of scholarly activity ........................ 16 7.6 Services 17 8 . Conclusions ................................................................ 17 9 . Recommendations ............................................................ 18 Annex 1 List of participants ................................................... 22 Annex 2 Background papers ...................................................... 25